X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Research And Views Archives | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Archives... Don't Miss Anything, Ever!

Here you will find all the research and views that we post on Equitymaster. Use the tools to customize the results to suit your preference!
















Authors
 

Orchid Pharma: Cephalosporin drives growth

(Dec 26, 2003)

Orchid Chemicals & Pharmaceuticals (OCP) is mainly into the manufacture of bulk drugs, formulations and nutraceuticals. The company is the largest manufacturer and exporter of cephalosporin bulk drugs in India and is amongst the top five producers in the world. OCP recently announced its September quarter results. The company has emerged as a preferred choice for Cephalosporin bulk drug, and is reaping the benefits of the same. The company reported a 45% growth in topline and a robust 153% botto

Operating margins under pressure at Orchid Pharma

(Jan 29, 2000)

Orchid is a bulk drug manufacturer. The company's primary products are oral and sterile cephalosporins -cephalexin, cefradine and cefradroxyl. For the quarter ended December 1999 Orchid has reported a 38.7% jump in the topline. The operating margins excluding other income are under pressure. This has led to only a 19.3% jump in the bottomline. The company made placement of 10.7 million shares at Rs.175/ per share to Schroder Capital during the year.

Orchid takes over Ajanta bulk drug plant

(Jan 5, 2000)

Orchid Chemicals is acquiring the bulk drug facility of Ajanta Pharmaceuticals. The price tag that the company is to pay for the Aurangabad based plant has been fixed at Rs 210 m.


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MARKET STATS